Reslizumab
ATC R03DX08 · 5 markets · 6 records
Reslizumab
Forms
GB 2 records · 2 strengths
- 100 mg/10 mLinjectionCinqaero 100mg/10ml concentrate for solution for infusion vials
- 25 mg/2.5 mLinjectionCinqaero 100mg/10ml concentrate for solution for infusion vials
US 1 records · 1 strengths
- 10 mginjectionCINQAIR
CA 1 records · 1 strengths
- 10 mgliquidCINQAIR
ES 1 records · 1 strengths
- 100 mginjectionCINQAERO
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 CINQAERO
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.